Open AccessP1242: ZANUBRUTINIB AND RITUXIMAB REGIMEN COMBINED WITH INTRAVITREAL METHOTREXATE FOLLOWED BY ZANUBRUTINIB MAINTENANCE FOR TREAT‐NAIVE PRIMARY VITREORETINAL LYMPHOMA: A PROSPECTIVE PHASE II STUDY
Author(s) -
Zhang Y.,
Zhang X.,
Wang W.,
Zhang Y.,
Zhang M.F.,
Zhang W.,
Zhou D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847832.31897.96
Subject(s) - medicine , rituximab , regimen , intraocular lymphoma , oncology , phases of clinical research , lymphoma , toxicity